ArticleRevista panamericana de salud publica = Pan American journal of public health2025
Costa Rica's trans-fat ban impact on cardiovascular disease: a macrosimulation study.
Article in Revista panamericana de salud publica = Pan American journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study uses a modeling framework to assess the potential impact of implementing the World Health Organization (WHO) REPLACE strategy to reduce the intake of industrially produced trans-fatty acids (IP-TFAs) on cardiovascular disease (CVD) in Costa Rica. Methods: The TFA Macrosimulation Model was used to estimate reductions in CVD mortality under three regulatory scenarios: (1) setting IP-TFA limits at 2% in oils and fats and 5% in other foods; (2) applying a uniform 2% IP-TFA limit across all foods; and (3) implementing a complete ban on partially hydrogenated oils (PHOs). Results: The model estimates that enforcing a 2% IP-TFA limit across all foods could prevent or delay approximately 128 deaths annually (3.0% of CVD mortality), while a full PHO ban could avert about 215 deaths per year (5.0% of CVD mortality). Economically, the PHO ban could yield annual savings of approximately US$2.1 million by reducing productivity losses associated with premature mortality. Conclusion: Implementing the WHO REPLACE strategy has the potential to substantially reduce CVD mortality, while also improving the population's health and economic productivity. These findings offer strong evidence to advocate for regulatory actions in Costa Rica and other nations across the Americas region to eliminate IP-TFAs from the food supply.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.